Advancements in chemotherapy and immunotherapy have improved multiple myeloma survival rates, with 5-year relative survival increasing from 37.7% to 60.3% between 2000-2004 and 2015-2019. Treatment ...

Black survivors of multiple myeloma say the latest developments in treatment give them hope even as federal research cuts ...

Confirming what many cancer specialists have long believed, British researchers have shown that high-dose chemotherapy and a stem cell transplant together are far more effective against the bone ...

A joint research team led by Professor Park Sung-soo of the Department of Hematology at the Catholic University of Korea's Seoul St. Mary's Hospital and Professor Han Seung-hoon of the Department of ...

Please provide your email address to receive an email when new articles are posted on . The addition of subcutaneous daratumumab to triplet therapy improved outcomes in transplant-ineligible or ...

In the cancer type multiple myeloma, the malignant cells differ significantly from normal cells regarding the layer of chemical "tags" on DNA and proteins that control whether genes are turned on or ...

The result marks a potential advance for dual-targeting antibody drugs like Tecvayli, which are currently relegated to ...

We recommend that CTC should be routinely assessed and measured at diagnosis as part of risk evaluation,” study researchers wrote.

EHA New Multiple Myeloma Regimen Is Also Effective in Elderly A treatment regimen of lenalidomide and low-dose dexamethasone shows significant improvements in progression-free survival in patients ...